GB Group Ord Shs GBGPF

GB Group plc is a United Kingdom-based company, which provides identity data intelligence products and services helping organizations recognize and verify all elements of an individual's identity at key interactions in their business processes. The Company's segments include location, identity and fraud. The location segment includes address lookup, verification and capture; e-mail validation; phone verification, and data maintenance services. The identity segment includes document verification, data verification and identity investigation services. Its identity verification solutions can be configured to carry out a wide range of functions, including know your customer checks, anti-money laundering checks, age verification checks and liveness detection. The fraud segment includes transaction fraud monitoring, combating origination fraud and in-life fraud investigation services. It provides artificial intelligence powered screening for automatic onboarding or referral of customers.

OTCPK:GBGPF - Post by User

GB Group Ord Shs > It's The OILS Baby, Purple GOLD !!!

<< Previous

Bullboard Posts

Next >>

Comment by PROtradingon Jan 10, 2018 11:13am

63 Views

Post# 27323389

RE:It's The OILS Baby, Purple GOLD !!!

HUGE! 100% agreed. Eigen337, we've played the oils together, makes sense to play these oils now huh?

Do you see a better deal than CMED anywhere? I'm pretty new to this sector but that's where I'm spending all my research time. HIGH DRIVE!!!! LOL

Eigen337 wrote: From:
CanniMed to supply weed to Germany through Fagron

2018-01-10 07:31 ET - News Release

Mr. Brent Zettl reports

CANNIMED THERAPEUTICS INC. ANNOUNCES STRATEGIC INTERNATIONAL CANNABIS DISTRIBUTION AGREEMENT WITH FAGRON NV

""Fagron is perfectly positioned in the highly attractive German market as well as several other countries to drive the penetration of our pharmaceutical grade cannabis products. Our first primary target market, Germany, is particularly exciting as it has legalized medicinal cannabis for distribution through pharmacies and with a population of over 82 million which is more than double that of Canada" said Brent Zettl, President and CEO, CanniMed. "Fagron brings the connections, experience and market credibility to be a highly impactful partner for us internationally. We anticipate that the majority of medicinal cannabis products demanded in these countries will be oils and oil derivate products such as capsules, sublingual wafers and topical creams. The first 12 million 60 ml bottles phase of our 50 million bottles per year oils plant will be coming onstream in late 2018 and will be the foundation for meeting escalating international and domestic medicinal oils demand."

**********

This is my opinion only.

Eigen337